Project Grant HT94252310189
Award Date
9/1/23
Completion Date
8/31/27
Dollars Obligated
$4M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
East Hanover, NJ 07936, USA
Similar Awards
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program provides $2,727,158.00 to the Kessler Foundation, Inc. to conduct research on "Personalized Cognitive Integrated Motor Training Using Virtual Reality to Improve Gait and Balance." The award period runs from September 30, 2024 to September 29, 2028. The Kessler Foundation, a non-profit rehabilitation research organization, will...
The Department of the Army Medical Command awarded a $718,090.00 Project Grant to the Kessler Foundation, Inc. under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "NEUROBALANCE: NEUROMODULATION ENHANCED USE OF ROBOTIC BALANCE TRAINING TO IMPROVE POSTURAL CONTROL IN TBI", will support research to develop new treatments and interventions to improve postural control and rehabilitation outcomes for individuals with traumatic brain...
The Defense Health Agency awarded a $1,493,220 Project Grant to The Cleveland VA Medical Research & Education Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a "Neurally Integrated Lower Limb Prosthesis for Home and Community Use" to aid mobility and sensory restoration for wounded veterans. The 4-year project, running from September 2023 to August 2027, aligns with the program's priorities of advancing...
This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) program, provides $325,142 to Onward Medical Inc. to develop a clinical-grade spinal cord neuroprosthesis to alleviate locomotor deficits in people with Parkinson's disease. The award has a performance period from September 1, 2025 to August 31, 2028. The CFDA 12.420 program supports advanced biomedical research to transform healthcare for military service members, veterans,...
The U.S. Defense Health Agency awarded a $490,602 Project Grant to the Ecole Polytechnique Federale De Lausanne (EPFL) in Switzerland under the Military Medical Research and Development (CFDA 12.420) program. The grant supports the development of a clinical-grade spinal cord neuroprosthesis to alleviate locomotor deficits in people with Parkinson's disease. The project aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical...
The federal Project Grant award of $799,998.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by The Cleveland Clinic Foundation to develop strategies for enhancing spinal plasticity to promote recovery from spinal cord injury. The 3-year award, which began on September 15, 2025, will fund innovative biomedical research focused on transforming healthcare for military service members, veterans, and the public. The Cleveland...
This $2,467,635 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program will fund the "THE IM ABLE 2 STUDY: LONG TERM OUTCOMES TO ADVANCE CARE FOR WARRIORS AND VETERANS USING ADVANCED ANKLE FOOT ORTHOSES" at the University of South Florida (USF) from June 15, 2025 to June 14, 2029. The funding will support advanced biomedical research aimed at transforming healthcare for military service members and veterans,...
The federal Project Grant award of $1,793,411 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Rehabilitation Institute of Chicago (doing business as Shirley Ryan AbilityLab), a non-profit hospital and research institute. The funding will support a research project titled "SAFETY AND EFFICACY OF AMPAKINES FOR IMPROVEMENT OF BLADDER FUNCTION IN INDIVIDUALS WITH SCI" over the period of July 1, 2024 to June 30,...
This federal Project Grant award, worth $2,966,875.00, was made by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a prospective clinical trial to investigate the optimal timing of surgical decompression for patients with acute spinal cord injuries. The grant recipient, the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, will conduct the research at its facility in Torrance, California over a...
This $505,228 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research to investigate joint-level pathomechanics and preserving knee joint health after lower limb loss through simulated ambulation. The grant was awarded to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., a non-profit organization located in Bethesda, Maryland, to conduct this advanced biomedical research over a...